(TAK) Takeda Pharmaceutical - Performance 18.1% in 12m
TAK performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
5.53%
#58 in Peer-Group
Rel. Strength
68.33%
#2410 in Stock-Universe
Total Return 12m
18.12%
#45 in Peer-Group
Total Return 5y
0.09%
#70 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 65.1 |
| P/E Forward | 14.4 |
| High / Low | USD |
|---|---|
| 52 Week High | 15.39 USD |
| 52 Week Low | 12.31 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 78.69 |
| Buy/Sell Signal +-5 | -0.87 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: TAK (18.1%) vs XLV (-5.1%)
5y Drawdown (Underwater) Chart
Top Performer in Pharmaceuticals
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-4.5% | 145% | 360% | 61.3 | 55.3 | 0.61 | 23.7% | -5.15% |
| LLY NYSE Eli Lilly |
12% | -6.78% | 514% | 66.1 | 37 | 1.24 | 58.2% | 18.9% |
| NVS NYSE Novartis |
10.1% | 17.9% | 81.6% | 18.5 | 14 | 1.37 | 8.70% | 9.2% |
| NOVN SW Novartis |
7.55% | 7.58% | 54.8% | 18.7 | 14.1 | 1.38 | 9.80% | 11.2% |
| SFZN SW Siegfried Holding |
-0.63% | 2.28% | 140% | 26.1 | 25 | 1.48 | 77.8% | 77.6% |
| GSK NYSE GlaxoSmithKline |
10% | 4.92% | 57.7% | 19.9 | 9.2 | 0.4 | -25.2% | 3.11% |
| AZN NASDAQ AstraZeneca |
9.51% | -4.27% | 58.6% | 28.9 | 15.9 | 0.96 | 52.7% | 22.3% |
| IPN PA Ipsen |
2.14% | -13% | 54.2% | 24.4 | 10.3 | 0.74 | -6.40% | -6.33% |
Performance Comparison: TAK vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for TAK
| Total Return (including Dividends) | TAK | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 8.57% | 4.35% | 1.11% |
| 3 Months | 0.13% | -6.89% | 5.58% |
| 12 Months | 18.12% | -5.08% | 10.51% |
| 5 Years | 0.09% | 50.53% | 109.12% |
| Trend Score (consistency of price movement) | TAK | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 94.8% | 65.8% | 69.9% |
| 3 Months | -7% | -72% | 69.3% |
| 12 Months | 54.5% | -62.2% | 43.2% |
| 5 Years | -18.2% | 88.5% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
|---|---|---|---|
| 1 Month | #71 | 4.05% | 7.38% |
| 3 Month | #85 | 7.54% | -5.16% |
| 12 Month | #45 | 24.44% | 6.89% |
| 5 Years | #74 | -33.51% | -52.13% |
FAQs
Does Takeda Pharmaceutical (TAK) outperform the market?
Yes,
over the last 12 months TAK made 18.12%, while its related Sector, the Health Care Sector SPDR (XLV) made -5.08%.
Over the last 3 months TAK made 0.13%, while XLV made -6.89%.
Performance Comparison TAK vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
TAK vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 1.5% | 7.5% | 15.5% | 8% |
| US NASDAQ 100 | QQQ | 1.7% | 7.1% | 16.2% | 9% |
| German DAX 40 | DAX | 3.7% | 9.3% | -0.9% | -11% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 1.7% | 9.5% | 13.6% | 7% |
| Hongkong Hang Seng | HSI | 1% | 3.5% | -3.6% | -9% |
| India NIFTY 50 | INDA | 3.2% | 9.9% | 16.5% | 20% |
| Brasil Bovespa | EWZ | -0.9% | 8.1% | -4.7% | 9% |
TAK vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 1.8% | 7.1% | 12.7% | -5% |
| Consumer Discretionary | XLY | 2% | 10.4% | 25.3% | 0% |
| Consumer Staples | XLP | 1.8% | 8.8% | 14% | 11% |
| Energy | XLE | -4.4% | 5.7% | 11.9% | 15% |
| Financial | XLF | 3% | 11.1% | 12.6% | -6% |
| Health Care | XLV | -0.5% | 4.2% | 15.9% | 23% |
| Industrial | XLI | 2.5% | 8.2% | 9.9% | -0% |
| Materials | XLB | 2.1% | 7.2% | 14.7% | 19% |
| Real Estate | XLRE | 0.9% | 7.6% | 14.5% | 5% |
| Technology | XLK | 1.2% | 6.6% | 15.1% | 14% |
| Utilities | XLU | 0.1% | 8% | 7.1% | -3% |
| Aerospace & Defense | XAR | 2.5% | 2.8% | -1.5% | -25% |
| Biotech | XBI | 1.8% | 0.8% | 26.2% | 26% |
| Homebuilder | XHB | 3.1% | 13.6% | 30.9% | 28% |
| Retail | XRT | 5.4% | 8.7% | 23.4% | 17% |
TAK vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -10.3% | -10.1% | 5.61% | 15% |
| Natural Gas | UNG | 2.2% | 11.2% | -2.8% | 33% |
| Gold | GLD | -2.2% | 2.4% | -14.7% | -29% |
| Silver | SLV | 2.3% | -2.8% | -4.1% | -4% |
| Copper | CPER | 4% | 6.9% | 0.6% | 10% |
TAK vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -0% | 7.9% | 16.9% | 22% |
| iShares High Yield Corp. Bond | HYG | 1% | 8.1% | 11.8% | 9% |